Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice.. Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice.: Gene expression profiles in mouse malaria

Archive ouverte

Delahaye, Nicolas, F. | Coltel, Nicolas | Puthier, Denis | Flori, Laurence | Houlgatte, Rémi | Iraqi, Fuad, A. | Nguyen, Catherine | Grau, Georges, E. | Rihet, Pascal

Edité par CCSD ; Oxford University Press -

International audience. The development of cerebral malaria (CM) in mice with Plasmodium berghei ANKA infection is under genetic control. Brain gene-expression patterns were investigated in well-defined genetically CM-resistant (CM-R; BALB/c and DBA/2) and CM-susceptible (CM-S; C57BL/6 and CBA/J) mice by use of cDNA microarrays. By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we identified a set of 69 genes that perfectly discriminated between mouse strains and between CM-R and CM-S mice. The analysis of gene ontological terms revealed that the genes that clustered and were related to susceptibility to CM preferentially belonged to some biological process classes, such as those pertaining to immune responses. Using a false discovery rate of 5% and the Welch t test, we identified 31 genes with consistent differential expression between CM-R and CM-S mice. These data indicate that microarray analysis may be useful for identification of candidate genes that are potentially responsible for resistance or susceptibility to mouse CM and suggest that candidate genes identified in mice could be specifically tested in humans for an association with disease severity.

Suggestions

Du même auteur

Family-based association of a low producing lymphotoxin-alpha allele with reduced Plasmodium falciparum parasitemia

Archive ouverte | Barbier, Mathieu | CCSD

International audience. no abstract

Association analyses of NCR3 polymorphisms with P-falciparum mild malaria

Archive ouverte | Delahaye, Nicolas F. | CCSD

International audience. no abstract

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.

Archive ouverte | Ménard, Cédric | CCSD

International audience. Clinical outcomes of gastrointestinal stromal tumor (GIST)-bearing patients treated with imatinib mesylate (IM) are variable. Other than the site of mutation within the c-kit gene, prognostic...

Chargement des enrichissements...